Evidence map›Paper›PMID 33070776›Full record

ArticleJournal of neuroinflammation2020

Neuroprotective effects of verbascoside against Alzheimer's disease via the relief of endoplasmic reticulum stress in Aβ-exposed U251 cells and APP/PS1 mice.

Chunyue Wang, Xueying Cai, Ruochen Wang, Siyu Zhai, Yongfeng Zhang, Wenji Hu, Yizhi Zhang, Di Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Beneficial Effects ofAntioxidants (Basel, Switzerland) · 2024
    Article
  17. Article
  18. Article
  19. Verbascoside-Rich Plant Extracts in Animal Nutrition.Antioxidants (Basel, Switzerland) · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Chunyue WangSchool of Life Sciences, Jilin University, Changchun, 130012, China.
Xueying CaiSchool of Life Sciences, Jilin University, Changchun, 130012, China.
Ruochen WangSchool of Life Sciences, Jilin University, Changchun, 130012, China.
Siyu ZhaiSchool of Life Sciences, Jilin University, Changchun, 130012, China.
Yongfeng ZhangSchool of Life Sciences, Jilin University, Changchun, 130012, China.
Wenji HuSchool of Life Sciences, Jilin University, Changchun, 130012, China.
Yizhi ZhangDepartment of Neurology, The Second Hospital of Jilin University, Changchun, 130041, China. yzzhang@jlu.edu.cn.
Di WangSchool of Life Sciences, Jilin University, Changchun, 130012, China. jluwangdi@outlook.com.ORCID http://orcid.org/0000-0002-6221-0949
Jilin University · CN

Funding

Industrial Technology Research and Development Projects from Development and Reform Commission of Jilin Province of P. R. China 2019C050-8the "13th Five-year" Science and Technology Projects from Education Department in Jilin Province of P. R. China JJKH20190108KJthe National Key Research & Development Program of China 2018YFE0107800
6 · The paper itself

Abstract

backgroundEndoplasmic reticulum (ER) stress is involved in the progression of Alzheimer's disease (AD). Verbascoside (VB), an active phenylethanoid glycoside that was first isolated from Verbascum sinuatum (the wavyleaf mullein), possesses anti-inflammatory, antioxidative, and anti-apoptotic effects. The purpose of this study was to elucidate the beneficial effects of VB in amyloid β (Aβ)

methodsU251 cells were co-incubated with 10 μM of Aβ

resultsIn Aβ

conclusionsThe results confirmed that VB possesses significant neuroprotective effects, which are related to the reduction of ER stress. These findings support the status of VB as a potentially effective treatment for AD and warrant further research.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsCell LineCell SurvivalDose-Response Relationship, DrugEndoplasmic Reticulum StressGlucosidesImmunosuppressive AgentsMaleMiceMice, TransgenicNeuroprotective AgentsPeptide FragmentsPhenolsacteosideAmyloid beta-Peptidesamyloid beta-protein (1-42)Amyloid beta-Protein PrecursorGlucosidesImmunosuppressive AgentsNeuroprotective AgentsPeptide FragmentsPhenolsPolyphenolsPresenilin-1Alzheimer’s diseaseAβEndoplasmic reticulum stressUnfolded protein responseVerbascoside

Identifiers

PMID33070776
PMCPMC7570123
OpenAlexW3092837411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.